Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
by Dr Roger Bloor and
Professor Ilana Crome
Published: April 2006
The prevalence of
co-existing substance misuse and psychiatric disorder (dual
diagnosis, comorbidity) has increased over the past decade, and the
indications are that it will continue to rise.
In recent years there have been unprecedented developments in
the pharmacological treatment of alcohol, opiate and nicotine
misuse. Here we evaluate the evidence on the use of some of these
treatments in dual diagnosis (with psychotic, mood and anxiety
disorders). The evidence base is limited by the exclusion of mental
illness when pharmacological agents for substance misuse are
evaluated and vice versa.
We set the available information within the context of the
psychosocial management of comorbid substance misuse and mental
illness, and the framework for service delivery recommended by UK
The module will take you through some of the key points with
If you like this module, you may also be
Stimulants: epidemiology and impact on mental
health by Professor Fabrizio Schifano and Dr Antonio
Substance misuse in older people by Dr Rahul Rao
and Professor Ilana Crome
depression in later life by Professor Robert Baldwin, Dr Deepak
K Sachdeva and Dr Amit Nulkar
Related Advances articles
Download take-home notes to print and